Savella and Hydrocodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Savella (milnacipran hydrochloride) and Hydrocodone (hydrocodone bitartrate; ibuprofen). Common drug interactions include chronic kidney disease among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Savella and Hydrocodone. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Savella?

Savella has active ingredients of milnacipran hydrochloride. It is often used in fibromyalgia. eHealthMe is studying from 7,529 Savella users. Check the latest studies of Savella.

What is Hydrocodone?

Hydrocodone has active ingredients of hydrocodone bitartrate; ibuprofen. eHealthMe is studying from 13,115 Hydrocodone users. Check the latest studies of Hydrocodone.



On Jul, 16, 2026

31 people who take Savella and Hydrocodone together, and have interactions are studied.

Savella and Hydrocodone drug interactions.

What are the common drug interactions of Savella and Hydrocodone, by gender? *:

female:

  1. Chronic kidney disease
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Dizziness
  4. Eyelid ptosis (falling of the upper or lower eyelid)
  5. Herpes simplex (herpes simplex is a common viral infection)
  6. Injection site discolouration
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Renal failure (kidney dysfunction)
  9. Sinusitis (inflammation of sinus)
  10. Breast cancer

male:

  1. Cellulitis (infection under the skin)
  2. Cough
  3. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  4. Myoclonic epilepsy (type of epilepsy with quick little jerks of the arms, shoulder, or occasionally the legs)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Neuropathy peripheral (surface nerve damage)
  7. Oropharyngeal pain
  8. Weight decreased

What are the common drug interactions of Savella and Hydrocodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Chronic kidney disease
  3. Gastric bypass
  4. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  5. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  6. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  7. Renal failure (kidney dysfunction)
  8. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

50-59:

  1. Dizziness
  2. Injection site discolouration
  3. Psoriasis (immune-mediated disease that affects the skin)
  4. Sinusitis (inflammation of sinus)
  5. Chest wall mass
  6. Dry throat
  7. Herpes simplex (herpes simplex is a common viral infection)
  8. Injection site swelling
  9. Skin discolouration (change of skin colour)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

60+:

  1. Neuropathy peripheral (surface nerve damage)
  2. Breast cancer
  3. Limb injury
  4. Lower limb fracture
  5. Memory impairment
  6. Muscular weakness (muscle weakness)
  7. Myoclonic epilepsy (type of epilepsy with quick little jerks of the arms, shoulder, or occasionally the legs)
  8. Nausea (feeling of having an urge to vomit)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Neuralgia (pain in one or more nerves)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 38.71%
  2. Pain: 9 people, 29.03%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 25.81%
  4. Depression: 7 people, 22.58%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 19.35%
  6. Stress And Anxiety: 6 people, 19.35%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 16.13%
  8. Asthma: 4 people, 12.90%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 9.68%
  10. Chest Pain: 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Savella and Hydrocodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Savella and Hydrocodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Savella:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydrocodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Savella and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydrocodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on milnacipran hydrochloride and hydrocodone bitartrate; ibuprofen (the active ingredients of Savella and Hydrocodone, respectively), and Savella and Hydrocodone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: